Jichuan Pharmaceutical Subsidiary Gets Certificates for Pediatric Laxative and Mesalazine Granules
Jichuan Pharmaceutical announced that its wholly-owned subsidiary, Jichuan Pharmaceutical Group Co. , Ltd. , has received the Drug Registration Certificates for Pediatric Laxative Granules and Mesalazine Slow-Release Granules, as approved and issued by the National Medical Products Administration (NMPA). The certificates cover two drugs, and the relevant registration information has officially taken effect.
Why this event matters
The event has a measured impact on 2 industrys. The strongest current signal is positive for Pharmaceuticals, with intensity 35/100 and 70% confidence over a short term horizon.
Healthcare · 13.1
Pharmaceuticals
- Direction
- positive
- Intensity
- 35
- Confidence
- 70%
- Horizon
- Short term
Traditional Chinese Medicine
- Direction
- positive
- Intensity
- 35
- Confidence
- 70%
- Horizon
- Short term
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.